Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.
Section 4201.206 - Opportunity to Discuss Treatment Before Adverse Determination(a) Subject to Subsection (b) and the notice requirements of Subchapter G, before an adverse determination is issued by a utilization review agent who questions the medical necessity, the appropriateness, or the experimental or investigational nature of a health care service, the agent shall provide the health care provider who ordered, requested, provided, or is to provide the service a reasonable opportunity to discuss with a physician licensed to practice medicine in this state the patient's treatment plan and the clinical basis for the agent's determination.(b) If the health care service described by Subsection (a) was ordered, requested, or provided, or is to be provided by a physician, the opportunity described by that subsection must be with a physician licensed to practice medicine in this state and who has the same or similar specialty as the physician.Tex. Ins. Code § 4201.206
Amended by Acts 2021, Texas Acts of the 87th Leg. - Regular Session, ch. 1018,Sec. 4, eff. 9/1/2021, op. for a request for preauthorization of health care services made on or after January 1, 2022.Amended by Acts 2019, Texas Acts of the 86th Leg.- Regular Session, ch. 1218,Sec. 3.03, eff. 9/1/2019.Amended By Acts 2009, 81st Leg., R.S., Ch. 1330, Sec. 9, eff. 9/1/2009.Added by Acts 2005, 79th Leg., Ch. 727, Sec. 4, eff. 4/1/2007.